Literature DB >> 10982359

Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells.

J Xiang1, S Wünschmann, W Schmidt, J Shao, J T Stapleton.   

Abstract

GB virus C (GBV-C or hepatitis G virus) is a recently described flavivirus which frequently leads to chronic viremia in humans. Although GBV-C is associated with acute posttransfusion hepatitis, it is not clear if the virus is pathogenic for humans. We constructed a full-length cDNA from the plasma of a person with chronic GBV-C viremia. Peripheral blood mononuclear cells (PBMCs) transfected with full-length RNA transcripts from this GBV-C clone resulted in viral replication. This was demonstrated by serial passage of virus from cell culture supernatants, detection of increasing concentrations of positive- and negative-sense GBV-C RNA over time, and the detection of the GBV-C E2 antigen by confocal microscopy. In addition, two types of GBV-C particles were identified in cell lysates; these particles had buoyant densities of 1.06 and 1.12 to 1.17 g/ml in sucrose gradients. PBMCs sorted for expression of CD4 contained 100-fold-more GBV-C RNA than CD4-negative cells. Taken together, these data demonstrate that RNA transcripts from GBV-C full-length cDNA are infectious in primary CD4-positive T cells. In contrast, RNA transcripts from an infectious hepatitis C virus clone did not replicate in the same cell culture system. Infectious RNA transcripts from GBV-C cDNA should prove useful for studying viral replication and may allow identification of differences between GBV-C and hepatitis C virus cultivation in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982359      PMCID: PMC102111          DOI: 10.1128/jvi.74.19.9125-9133.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

Authors:  A A Kolykhalov; E V Agapov; K J Blight; K Mihalik; S M Feinstone; C M Rice
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

2.  Prevalence and risk factor analysis of GBV-C/HGV infection in prostitutes.

Authors:  J C Wu; W Y Sheng; Y H Huang; S J Hwang; S D Lee
Journal:  J Med Virol       Date:  1997-05       Impact factor: 2.327

3.  Full or partial seroreversion in patients infected by hepatitis C virus.

Authors:  J J Lefrère; S Guiramand; F Lefrère; M Mariotti; P Aumont; J Lerable; J C Petit; R Girot; L Morand-Joubert
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

4.  Hepatitis G virus replication in human cultured cells displaying susceptibility to hepatitis C virus infection.

Authors:  M Ikeda; K Sugiyama; T Mizutani; T Tanaka; K Tanaka; K Shimotohno; N Kato
Journal:  Biochem Biophys Res Commun       Date:  1997-06-27       Impact factor: 3.575

5.  Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization.

Authors:  J N Simons; S M Desai; D E Schultz; S M Lemon; I K Mushahwar
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  GB virus C, hepatitis G virus, or human orphan flavivirus?

Authors:  D Theodore; S M Lemon
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

7.  Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction.

Authors:  G J Dawson; G G Schlauder; T J Pilot-Matias; D Thiele; T P Leary; P Murphy; J E Rosenblatt; J N Simons; F E Martinson; R A Gutierrez; J R Lentino; C Pachucki; A S Muerhoff; A Widell; G Tegtmeier; S Desai; I K Mushahwar
Journal:  J Med Virol       Date:  1996-09       Impact factor: 2.327

8.  Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee.

Authors:  M Yanagi; R H Purcell; S U Emerson; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

9.  The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.

Authors:  H J Alter; Y Nakatsuji; J Melpolder; J Wages; R Wesley; J W Shih; J P Kim
Journal:  N Engl J Med       Date:  1997-03-13       Impact factor: 91.245

10.  The entire nucleotide sequences of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan.

Authors:  H Okamoto; H Nakao; T Inoue; M Fukuda; J Kishimoto; H Iizuka; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1997-04       Impact factor: 3.891

View more
  46 in total

1.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 2.  GB virus type C: a beneficial infection?

Authors:  Jack T Stapleton; Carolyn F Williams; Jinhua Xiang
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 3.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

4.  GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expression.

Authors:  Robert T Rydze; Jinhua Xiang; James H McLinden; Jack T Stapleton
Journal:  J Infect Dis       Date:  2012-04-25       Impact factor: 5.226

5.  Human Pegivirus infection and lymphoma risk and prognosis: a North American study.

Authors:  Angelo Fama; Jinhua Xiang; Brian K Link; Cristine Allmer; Donna Klinzman; Andrew L Feldman; Grzegorz S Nowakowski; Mark Liebow; Melissa C Larson; Matthew J Maurer; Stephen M Ansell; Anne J Novak; Yan W Asmann; Susan L Slager; Timothy G Call; Thomas M Habermann; James R Cerhan; Jack T Stapleton
Journal:  Br J Haematol       Date:  2018-05-29       Impact factor: 6.998

6.  GBV-C infection and risk of NHL among U.S. adults.

Authors:  Cindy M Chang; Jack T Stapleton; Donna Klinzman; James H McLinden; Mark P Purdue; Hormuzd A Katki; Eric A Engels
Journal:  Cancer Res       Date:  2014-08-12       Impact factor: 12.701

7.  Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.

Authors:  Jinhua Xiang; James H McLinden; Thomas M Kaufman; Emma L Mohr; Nirjal Bhattarai; Qing Chang; Jack T Stapleton
Journal:  Virology       Date:  2012-05-16       Impact factor: 3.616

Review 8.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

9.  Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.

Authors:  Jinhua Xiang; James H McLinden; Robert A Rydze; Qing Chang; Thomas M Kaufman; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.

Authors:  James H McLinden; Jack T Stapleton; Donna Klinzman; Krishna K Murthy; Qing Chang; Thomas M Kaufman; Nirjal Bhattarai; Jinhua Xiang
Journal:  J Gen Virol       Date:  2013-01-03       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.